Novartis AG Shortterm Restructuring Provision
Novartis AG (NVSEF) had Shortterm Restructuring Provision of $332.00 million as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:ShorttermRestructuringProvision · last filed 2026-02-04
- 2025-12-31: Shortterm Restructuring Provision $332.00M.
- 2024-12-31: Shortterm Restructuring Provision $424.00M.
- 2023-12-31: Shortterm Restructuring Provision $703.00M.
- 2022-12-31: Shortterm Restructuring Provision $1.13B.
| Period end | Shortterm Restructuring Provision |
|---|---|
| 2025-12-31 | $332.00M 20-F · filed 2026-02-04 |
| 2024-12-31 | $424.00M 20-F · filed 2026-02-04 |
| 2023-12-31 | $703.00M 20-F · filed 2025-01-31 |
| 2022-12-31 | $1.13B 20-F · filed 2024-01-31 |
| 2021-12-31 | $345.00M 20-F/A · filed 2023-05-15 |
| 2020-12-31 | $459.00M 20-F · filed 2022-02-02 |
| 2019-12-31 | $438.00M 20-F · filed 2021-01-26 |
| 2018-12-31 | $507.00M 20-F · filed 2020-01-29 |
| 2017-12-31 | $153.00M 20-F · filed 2019-01-30 |
| 2016-12-31 | $222.00M 6-K · filed 2018-01-24 |